4-5628743-TAA-TAAAAA
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS1
The NM_147127.5(EVC2):c.1711-10_1711-9insTTT variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000081 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00029 ( 0 hom. )
Consequence
EVC2
NM_147127.5 splice_polypyrimidine_tract, intron
NM_147127.5 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.151
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 4-5628743-T-TAAA is Benign according to our data. Variant chr4-5628743-T-TAAA is described in ClinVar as [Likely_benign]. Clinvar id is 1628699.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.000287 (365/1271090) while in subpopulation AFR AF= 0.00428 (135/31514). AF 95% confidence interval is 0.0037. There are 0 homozygotes in gnomad4_exome. There are 157 alleles in male gnomad4_exome subpopulation. Median coverage is 0. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EVC2 | NM_147127.5 | c.1711-10_1711-9insTTT | splice_polypyrimidine_tract_variant, intron_variant | ENST00000344408.10 | NP_667338.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EVC2 | ENST00000344408.10 | c.1711-10_1711-9insTTT | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_147127.5 | ENSP00000342144 | P2 | |||
EVC2 | ENST00000310917.6 | c.1471-10_1471-9insTTT | splice_polypyrimidine_tract_variant, intron_variant | 1 | ENSP00000311683 | A2 | ||||
EVC2 | ENST00000475313.5 | c.1471-10_1471-9insTTT | splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant | 1 | ENSP00000431981 | |||||
EVC2 | ENST00000509670.1 | c.*104-10_*104-9insTTT | splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant | 1 | ENSP00000423876 |
Frequencies
GnomAD3 genomes AF: 0.0000807 AC: 12AN: 148670Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
12
AN:
148670
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000287 AC: 365AN: 1271090Hom.: 0 Cov.: 0 AF XY: 0.000248 AC XY: 157AN XY: 632706
GnomAD4 exome
AF:
AC:
365
AN:
1271090
Hom.:
Cov.:
0
AF XY:
AC XY:
157
AN XY:
632706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000807 AC: 12AN: 148778Hom.: 0 Cov.: 0 AF XY: 0.0000552 AC XY: 4AN XY: 72510
GnomAD4 genome
AF:
AC:
12
AN:
148778
Hom.:
Cov.:
0
AF XY:
AC XY:
4
AN XY:
72510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 04, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at